Johnson & Johnson (JNJ)

145.24
NYSE
Prev Close 145.08
Day Low/High 144.35 / 147.47
52 Wk Low/High 109.16 / 157.00
Exchange NYSE
Shares Outstanding 2632.82B
Market Cap 381.97B
P/E Ratio 25.40
Div & Yield N.A. (N.A)

Latest News

Covid Surges, Playing Politics, Charting the Nasdaq and S&P 500, U.S. Outlook

Covid Surges, Playing Politics, Charting the Nasdaq and S&P 500, U.S. Outlook

Markets have certainly recovered nicely off of the lows of late September. Now, here in mid-October, it feels like it did that cold night back in 1980-something. The wolves are visible and noisy.

3 'Pick & Shovel' Stock Plays in Covid Vaccine Development

3 'Pick & Shovel' Stock Plays in Covid Vaccine Development

Investors are chasing every name that's developing a promising coronavirus vaccine. These stocks will be winners no matter which companies are successful.

Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade

Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade

Covid itself, and therapeutics or vaccines associated with taking on the SARS-CoV-2 coronavirus, is under a public microscope.

The Market Needs Some Rest but There Are Many Positives at Work

The Market Needs Some Rest but There Are Many Positives at Work

Market participants ignore negative news and continue to pursue individual stocks into earnings season.

We Fell, but It Could Have Been Worse

We Fell, but It Could Have Been Worse

Given the news of the day, you'd think we would have had a violent pullback -- instead here's what we got.

Jim Cramer: Let the Market's Patterns Guide You

Jim Cramer: Let the Market's Patterns Guide You

Some patterns reveal themselves easily, and you can spot them ahead of the computer programs. Here are examples of them, and how to act.

Jim Cramer: Here's How We're Going to Beat Covid-19

Jim Cramer: Here's How We're Going to Beat Covid-19

Let's talk about what's happening right now to get this thing under control and what it will look like not that long from now.

J&J's Pause, Nasdaq Thumbs Up, Amazon Prime Day, Apple Hi, Speed, Veeva Breakout

J&J's Pause, Nasdaq Thumbs Up, Amazon Prime Day, Apple Hi, Speed, Veeva Breakout

Now, that we have confirmation from the Nasdaq Composite, I think we can say equity markets are indeed back in what I would consider an uptrend.

Big-Cap Technology Regains Its Leadership as Banks Kick Off Earnings Season

Big-Cap Technology Regains Its Leadership as Banks Kick Off Earnings Season

There was some significant rotational action Monday and we'll see if that continues as we move into earnings reports.

Jim Cramer: Here's Why the President Is Gambling With Stimulus

Jim Cramer: Here's Why the President Is Gambling With Stimulus

The market is reflecting a triumph of big business over small business, and here's what that means for individual stocks.

Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.

Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.

Neither candidate seems to be the enemy of the market -- at least not yet.

With Q3 Earnings Up Ahead, Can Johnson & Johnson Set the Table?

With Q3 Earnings Up Ahead, Can Johnson & Johnson Set the Table?

I see no reason to flee this name, therefore, I am not.

Certainty of Uncertainty, Lines in the Sand, Election Fears, Fed Alone, Twitter

Certainty of Uncertainty, Lines in the Sand, Election Fears, Fed Alone, Twitter

The result has been a technical breakdown in risk-asset pricing -- and the main culprit is without a doubt, the inability of Congress to compromise.

Jim Cramer: Abbott's Rapid Covid-19 Test and My Super Bowl Dreams

Jim Cramer: Abbott's Rapid Covid-19 Test and My Super Bowl Dreams

Abbott Labs can bring back some normalcy to this country -- and the world -- with its BinaxNOW rapid antigen test along with its amazing Navica app.

Jim Cramer: We're Feeling the Wrath of the Sellers - And It's About Time

Jim Cramer: We're Feeling the Wrath of the Sellers - And It's About Time

The greedy are, at last, getting blown out, and the prudent being vindicated. I see three buckets of stocks that intrigue me now.

Auction Action

The 10-year U.S. note auction was soft. The yield of 0.704% was above the when issued of about 0.695%. The bid to cover of 2.30 was below the 12 month average of 2.47. Also, dealers were left with 27% of the auction vs. the one year average of 25%. ...

A Healthy Dose of Vaccine and Pharmaceutical Plays

A Healthy Dose of Vaccine and Pharmaceutical Plays

6 favorite stocks and ETFs in the biotech and pharmaceutical sector, including a diversified basket of Covid-19 vaccine names.

Jim Cramer: All These Stocks Are Not Quite 'Dow and Out'

Jim Cramer: All These Stocks Are Not Quite 'Dow and Out'

Let's look at the Dow Jones' swapping of Exxon for Salesforce, Pfizer for Amgen and Raytheon for Honeywell.

The Week Ahead, Markets Haven't Been Wrong, Closer to a Vaccine? Watching J&J

The Week Ahead, Markets Haven't Been Wrong, Closer to a Vaccine? Watching J&J

The equity market recovery is just as sloppy in performance as the economy itself.

The Nasdaq and Great Stock Picking Continue to Lead the Market Higher

The Nasdaq and Great Stock Picking Continue to Lead the Market Higher

If you're looking for some corrective action to gain momentum, then you will have to wait for broader selling.

Iconic Johnson & Johnson Is Poised for an Upside Breakout

Iconic Johnson & Johnson Is Poised for an Upside Breakout

Here's how we would trade the blue chip stock.

Emergent BioSolutions Could See Further Upside Gains

Emergent BioSolutions Could See Further Upside Gains

Most of the indicators are still bullish in this name, although some profit-taking may be occurring.

Jim Cramer: Betting Against Science Is a Mug's Game

Jim Cramer: Betting Against Science Is a Mug's Game

The buyers have decided that the researchers and doctors are going to beat the virus, so you better get on board or miss the move.

Parabolic AMD, Agreeing to Agree, Disney's GAAP Earnings Gap: Market Recon

Parabolic AMD, Agreeing to Agree, Disney's GAAP Earnings Gap: Market Recon

It is going to take successful vaccines and therapies and much lower unemployment to revive most of Walt Disney Co.'s businesses.

Jim Cramer: This Is Where to Put Your Cash as Covid Surges

Jim Cramer: This Is Where to Put Your Cash as Covid Surges

Instead of scratching your head and saying the market defies logic, look to the Cramer Covid-19 Index.

Big Tech's Big Night, Eyeing Amazon, My Kodak Moment, Powell's Blunt Assessment

Big Tech's Big Night, Eyeing Amazon, My Kodak Moment, Powell's Blunt Assessment

The Fed has done a lot, and is willing to do even more, but for now, is watching Congress. The fiscal side is where the next shoe falls.

Jim Cramer: I'm Sick of Hearing All This Nonsense About the Fed

Jim Cramer: I'm Sick of Hearing All This Nonsense About the Fed

Let me disabuse you of some of the biggest canards that people routinely spout involving the Fed and stocks.

Jim Cramer: Handicapping the Major Covid-19 Vaccine Makers

Jim Cramer: Handicapping the Major Covid-19 Vaccine Makers

Our fate is in the hands of a few dozen companies with a dizzying array of clinical trials, and whoever gets there first is gonna make a fortune.